Sildenafil Tablet, Film Coated
Product Images NDC 71335-0969

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-0969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350969)

This text appears to be a combination of product information for a medication containing Sildenafil Citrate and what may be a reference to a transaction or delivery involving Bunbank and Buyant Ranch. The medication is an oval-shaped, white tablet with 100mg of Sildenafil Citrate, which is commonly used to treat erectile dysfunction. The table should be stored at room temperature and kept out of reach of children. There are also some details provided about the prescription and manufacture, such as the label number and expiration date.*

FDA Label Image

10 (Sildenafil Tablets 25 50 100 1)

FDA Label Image

10 (Sildenafil Tablets 25 50 100 2)

This is a chart presenting the systolic blood pressure in mmHg before and after the administration of either sildenafil 100mg or placebo. The time post-dose is presented in hours.*

FDA Label Image

10 (Sildenafil Tablets 25 50 100 3)

This appears to be a graph of the change in systolic blood pressure (SBP) in mmHg over time (in hours) for two different treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The y-axis shows values from -40 to 20, while the x-axis maps the time points starting from 3 and ending at 8 hours post-dose. The graph suggests that Doxazosin + Sildenafil 25 mg may lead to a greater reduction in SBP compared to Doxazosin + Placebo.*

FDA Label Image

10 (Sildenafil Tablets 25 50 100 4)

The text provides a graph showing the change in SBP (systolic blood pressure) measured in mmHg over time in hours after taking either Doxazosin + Placebo or Doxazosin + Sildenafil 50 mg. The graph shows a decrease in SBP in both cases. The values on the x-axis range from 0 to 8 hours post-dose, and the values on the y-axis range from -50 mmHg to 0 mmHg.*

FDA Label Image

10 (Sildenafil Tablets 25 50 100 5)

This appears to be a graph or chart, but without additional context or labels it is not possible to provide a description.*

FDA Label Image

10 (Sildenafil Tablets 25 50 100 6)

FDA Label Image

10 (Sildenafil Tablets 25 50 100 7)

FDA Label Image

10 (Sildenafil Tablets 25 50 100 8)

FDA Label Image

10 (Sildenafil Tablets 25 50 100 9)

This appears to be a table showing the percentages of different treatment groups for a study involving Placebo and Sildenafil (25mg, 50mg, and 100mg doses). The study involved a total of 463 participants and the overall treatment was found to be statistically significant with a p-value of less than 0.0001. There is no further information available to provide additional context or interpretation.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.